oncologic outcomes
Cancer-specific survival and recurrence metrics used to evaluate treatment effectiveness in urologic malignancies.
Full Definition
Standardized endpoints measuring cancer control and patient survival following urologic oncology treatments. Key oncologic outcomes include overall survival, cancer-specific survival, recurrence-free survival, and metastasis-free survival. These metrics are distinguished from functional outcomes (such as continence or potency) and are considered the primary measures of treatment success. Oncologic outcomes are typically reported at specific time intervals (5-year, 10-year) and stratified by risk categories to enable meaningful comparisons between treatment approaches.
Usage
Usage note: Always specify the time frame and specific metrics when reporting oncologic outcomes.
In Context
- "Long-term oncologic outcomes favored radical over partial nephrectomy in this series." — Research publication
- "The study prioritized oncologic outcomes over functional preservation." — Clinical trial design